AbbVie
The Scientific Director, Oncology Early Development oversees the planning, execution, and interpretation of clinical trials in hematology, solid tumors, or cell therapy. This role leads cross‑functional teams to generate high‑quality clinical data, manages study design and regulatory submissions, and ensures compliance with Good Clinical Practices while collaborating with internal and external stakeholders.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
16% above the average for this role
Director, Clinical Science
Lyell Immunopharma
Senior / Principal Clinical Scientist, Clinical Development
immunomeinc
Senior Director, Clinical Science, Oncology Early Development (Hybrid)
MSD
Director, Clinical Science – Oncology Clinical Development
GSK plc
Director, Clinical Science – Oncology Clinical Development
GSK plc
Hematology/Oncology Medical Science Liaison (MSL)
GSK plc